Plasticity of the spinal neural circuitry after injury

Annual Review of Neuroscience
V R EdgertonR R Roy

Abstract

Motor function is severely disrupted following spinal cord injury (SCI). The spinal circuitry, however, exhibits a great degree of automaticity and plasticity after an injury. Automaticity implies that the spinal circuits have some capacity to perform complex motor tasks following the disruption of supraspinal input, and evidence for plasticity suggests that biochemical changes at the cellular level in the spinal cord can be induced in an activity-dependent manner that correlates with sensorimotor recovery. These characteristics should be strongly considered as advantageous in developing therapeutic strategies to assist in the recovery of locomotor function following SCI. Rehabilitative efforts combining locomotor training pharmacological means and/or spinal cord electrical stimulation paradigms will most likely result in more effective methods of recovery than using only one intervention.

References

Jul 1, 1976·Physiological Reviews·M L Shik, G N Orlovsky
Feb 21, 1975·Brain Research·H ForssbergS Rossignol
Jan 1, 1992·Brain Research Bulletin·T IwaharaR D Skinner
Jun 1, 1991·Journal of Applied Physiology·R R RoyV R Edgerton
Apr 30, 1990·Brain Research·R G LovelyV R Edgerton
Jan 1, 1985·Annual Review of Neuroscience·S Grillner, P Wallén
May 26, 1987·Brain Research·H Barbeau, S Rossignol
Nov 13, 1972·Brain Research·G N Orlovsky
Mar 1, 1980·Acta Physiologica Scandinavica·H ForssbergJ Halbertsma
Mar 1, 1980·Acta Physiologica Scandinavica·H ForssbergS Rossignol
Apr 1, 1995·The European Journal of Neuroscience·A WernigE Cagol
May 1, 1995·Annals of Neurology·V DietzL Baumgartner
Dec 1, 1994·Medicine and Science in Sports and Exercise·J A HodgsonV R Edgerton
Feb 1, 1997·Journal of Neurophysiology·S J HarkemaV R Edgerton
Feb 21, 1998·Journal of Neurophysiology·C ChauS Rossignol
Jul 25, 1998·Cytogenetics and Cell Genetics·C FedericoG Bernardi
Jan 16, 1999·Journal of Neuroscience Research·D Feraboli-LohnherrD Orsal
Jan 23, 1999·Journal of Neurophysiology·R D De LeonV R Edgerton
Feb 3, 1999·Annals of the New York Academy of Sciences·O Kiehn, O Kjaerulff
Feb 3, 1999·Annals of the New York Academy of Sciences·J R CazaletsF Clarac
Feb 3, 1999·Annals of the New York Academy of Sciences·B J SchmidtJ N MacLean
Feb 3, 1999·Annals of the New York Academy of Sciences·N Kudo, H Nishimaru
Feb 3, 1999·Annals of the New York Academy of Sciences·M R DimitrijevicM M Pinter
Mar 6, 1999·The Journal of Physiology·E B Simonsen, P Dyhre-Poulsen
Jul 17, 1999·Brain Research. Brain Research Reviews·H BarbeauM A Lemay
Apr 4, 2001·The European Journal of Neuroscience·F Gómez-PinillaV R Edgerton

❮ Previous
Next ❯

Citations

Jun 9, 2006·Experimental Brain Research·L LünenburgerV Dietz
Jan 17, 2012·Experimental Brain Research·D BarthélemyL J Bouyer
Jun 14, 2006·European Journal of Applied Physiology·Min LiuKrista Vandenborne
Aug 11, 2010·Biological cybernetics·Sarah Degallier, Auke Ijspeert
May 13, 2009·Current Treatment Options in Cardiovascular Medicine·Richard L Harvey
May 5, 2005·Experimental Neurology·Zhe YingFernando Gómez-Pinilla
Oct 3, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Alexander W DromerickJoseph Hidler
Feb 27, 2008·Behavioral Neuroscience·Michelle A HookJames W Grau
Oct 15, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ali MehannaMelitta Schachner
Jul 8, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jian ChenMelitta Schachner
Jul 22, 2006·Nature Reviews. Neuroscience·Glenn Yiu, Zhigang He
Jul 22, 2006·Nature Reviews. Neuroscience·Noam Y Harel, Stephen M Strittmatter
Jul 27, 2006·Journal of Neurotrauma·Stéphane VinitAnne Kastner
Apr 25, 2006·Journal of Neurotrauma·Theo Hagg, Martin Oudega
Apr 25, 2006·Journal of Neurotrauma·V Reggie EdgertonRoland R Roy
May 28, 2009·Journal of Neurotrauma·Myung-Jin OhUk Namgung
Jun 6, 2009·Journal of Neurotrauma·Harra R Sandrow-FeinbergJohn D Houle
May 4, 2011·Journal of Neurotrauma·Julieann C Durham-LeeOlivera Nesic
Nov 20, 2012·Journal of Neurotrauma·Felicitas WirthEckhard Schönau
Dec 7, 2007·Brain : a Journal of Neurology·Marc D KubasakPatricia E Phelps
Oct 2, 2013·Brain : a Journal of Neurology·Janine BeauparlantGrégoire Courtine
Jan 31, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Lindsey A CzarneckiJohn P McGann
Jan 10, 2006·Journal of Neurologic Physical Therapy : JNPT·Laurent J Bouyer
May 9, 2008·Journal of Neurologic Physical Therapy : JNPT·Barbara NashMichael G Parker
Nov 4, 2008·Journal of Neurologic Physical Therapy : JNPT·Mark G BowdenAndrea L Behrman
Aug 31, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·L L CaiV R Edgerton
Aug 31, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Irin C Maier, Martin E Schwab
Jan 19, 2005·The European Journal of Neuroscience·Angela L M ScottMatt S Ramer
Jun 17, 2006·Annual Review of Neuroscience·Ole Kiehn
Jan 24, 2009·Journal of Neurophysiology·V F LyalkaT G Deliagina
Mar 18, 2011·Cells, Tissues, Organs·Richard L SegalVicki S Mercer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.